Found: 9
Select item for more details and to access through your institution.
Expression and Purification of Neurotrophin-Elastin-Like Peptide Fusion Proteins for Neural Regeneration.
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 117, doi. 10.1007/s40259-016-0159-4
- By:
- Publication type:
- Article
Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 129, doi. 10.1007/s40259-016-0160-y
- By:
- Publication type:
- Article
Trastuzumab in the Treatment of Breast Cancer.
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 75, doi. 10.1007/s40259-016-0162-9
- By:
- Publication type:
- Article
Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 145, doi. 10.1007/s40259-016-0163-8
- By:
- Publication type:
- Article
The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic Agents.
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 105, doi. 10.1007/s40259-016-0164-7
- By:
- Publication type:
- Article
Management of Multiple Myeloma with Second-Generation Antibody-Drug Conjugates.
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 87, doi. 10.1007/s40259-016-0165-6
- By:
- Publication type:
- Article
Anti-EGFR Therapy for Metastatic Colorectal Cancer in the Era of Extended RAS Gene Mutational Analysis.
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 95, doi. 10.1007/s40259-016-0166-5
- By:
- Publication type:
- Article
Tbo-Filgrastim: A Review in Neutropenic Conditions.
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 153, doi. 10.1007/s40259-016-0172-7
- By:
- Publication type:
- Article
Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs).
- Published in:
- BioDrugs, 2016, v. 30, n. 2, p. 49, doi. 10.1007/s40259-016-0157-6
- By:
- Publication type:
- Article